TrialBlood2011

The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia.

Julia Hoellenriegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.